SCHEMBL6959322

SCHEMBL6959322

O=C(O)C(Sc1ccc2ccccc2c1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.57
SIRT5 Q9NXA8 2/20 0.47
ANPEP P15144 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
PPARG P37231 3/20 0.42
PPARA Q07869 3/20 0.42
AKR1C3 P42330 3/20 0.41
AKR1C2 P52895 3/20 0.41
MAPT P10636 2/20 0.41
PTPN7 P35236 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KIF11 P52732 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11024562 0.83 EPHX1 (0.56) EPHX1SIRT5ANPEPCES2CES1
SCHEMBL6965136 0.79 LMNA (0.46) MAPT
SCHEMBL4753499 0.79 EPHX1 (0.64) EPHX1SIRT5ANPEPPPARGPPARA
SCHEMBL7371798 0.76 EPHX1 (0.53) EPHX1ANPEPPPARGPPARAMAPT
SCHEMBL8557449 0.74 SIRT5 (0.51) EPHX1SIRT5ANPEPKIF11
SCHEMBL726873 0.74 ALDH1A1 (0.58) EPHX1SIRT5ANPEPMAPTMEN1
SCHEMBL8557443 0.74 SIRT5 (0.51) EPHX1SIRT5ANPEPKIF11
SCHEMBL1479596 0.74 ANPEP (0.49) EPHX1ANPEPCES2CES1MAPT
SCHEMBL9238244 0.73 EPHX1 (0.49) EPHX1SIRT5ANPEPPPARGPPARA
SCHEMBL9238238 0.73 EPHX1 (0.49) EPHX1SIRT5ANPEPPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed